10-QPeriod: Q3 FY2023

ECOLAB INC. Quarterly Report for Q3 Ended Sep 30, 2023

Filed November 2, 2023For Securities:ECL

Summary

Ecolab Inc. (ECL) reported strong third quarter and year-to-date results for 2023, demonstrating resilience and growth across its key segments. Net sales increased by 8% year-over-year for both the quarter and the nine-month period, reaching $3.96 billion and $11.38 billion, respectively. This growth was driven by a combination of solid pricing actions and modest volume increases, reflecting the company's ability to pass on costs and the demand for its essential products and services. Profitability saw a significant improvement, with reported operating income up 17% in the third quarter and 19% year-to-date. Diluted EPS also showed robust growth, increasing 17% for the quarter to $1.41 and 17% year-to-date to $3.38. The company's improved gross margin, up to 41.1% in the third quarter from 37.5% in the prior year, highlights effective cost management and pricing strategies. The company also made significant progress on its restructuring programs, driving further efficiencies and contributing to the overall improved financial performance.

Financial Highlights

53 data points
Beta

Revenue

$3.96B

41.1% Gross Margin

Net Income

$404.00M

10.2% Net Margin

EPS (Diluted)

$1.41

Total Assets

$21.86B

Cash & Equivalents

$1.00B

Free Cash Flow

$621.20M

Financial Statements
Beta
Revenue$3.96B
Cost of Revenue$2.33B
Gross Profit$1.63B
SG&A Expenses$1.02B
Operating Income$566.00M
Interest Expense$91.30M
Net Income$404.00M
EPS (Basic)$1.42
EPS (Diluted)$1.41
Shares Outstanding (Basic)285.10M
Shares Outstanding (Diluted)286.90M

Key Highlights

  • 1Net sales increased by 8% to $3.96 billion for Q3 2023 and by 8% to $11.38 billion for the first nine months of 2023, driven by organic growth and pricing.
  • 2Reported operating income increased by 17% to $566.0 million for Q3 2023 and by 21% to $1,402.3 million for the first nine months of 2023.
  • 3Diluted EPS rose by 17% to $1.41 for Q3 2023 and by 17% to $3.38 for the first nine months of 2023.
  • 4Gross margin improved to 41.1% in Q3 2023 from 37.5% in Q3 2022, indicating successful pricing strategies and cost management.
  • 5Organic sales growth was strong across segments: Global Industrial (4% Q3), Global Institutional & Specialty (11% Q3), and Global Healthcare & Life Sciences (11% Q3).
  • 6The company is progressing with its restructuring programs, including the Combined Program and Institutional Advancement Program, which are expected to yield further cost savings.
  • 7Ecolab maintained a strong liquidity position with $1,001.3 million in cash and cash equivalents as of September 30, 2023.

Frequently Asked Questions

Ecolab's sales growth in Q3 2023 was primarily driven by a combination of strong pricing actions across its segments and modest volume increases. Organic sales increased by 7% overall, with specific segments like Global Institutional & Specialty and Global Healthcare & Life Sciences showing double-digit growth.

Profitability has significantly improved. Reported operating income increased by 17% year-over-year for Q3 2023, and diluted EPS grew by 17% to $1.41. This improvement is supported by a strong increase in gross margin to 41.1% and effective cost management.

Ecolab is actively executing its restructuring programs, such as the Combined Program and Institutional Advancement Program, which are focused on cost savings and operational efficiencies. These programs are contributing to improved profitability and are expected to deliver further annualized cost savings in the coming periods.

Ecolab maintains a strong financial position and liquidity. As of September 30, 2023, the company held $1,001.3 million in cash and cash equivalents. Total debt remained stable, and the company is in compliance with its debt covenants, indicating a healthy ability to meet its financial obligations and fund future operations.